Literature DB >> 12617912

Cytotoxic activity of 6-alkynyl- and 6-alkenylpurines.

Anders Bråthe1, Lise-Lotte Gundersen, Jon Nissen-Meyer, Frode Rise, Bjørn Spilsberg.   

Abstract

6-Alkynyl- and 6-alkenylpurines have been screened for cytotoxic activity against a human chronic myelogenous leukemia cell line; K-562 cells using a [(3)H]-thymidine incorporation assay. Most alkynes displayed cytotoxicity comparable to, or better than, the known anticancer drugs 6-mercaptopurine and fludarabine. The 6-alkenylpurines, which are promising plant growth stimulators and 15-lipoxygenase inhibitors, exhibited only low toxicity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12617912     DOI: 10.1016/s0960-894x(03)00011-8

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  Efficient Pd-catalyzed coupling of tautomerizable heterocycles with terminal alkynes via C-OH bond activation using PyBrOP.

Authors:  Ce Shi; Courtney C Aldrich
Journal:  Org Lett       Date:  2010-05-21       Impact factor: 6.005

2.  Synthesis and anticancer activity of thiosubstituted purines.

Authors:  Alicja Kowalska; Małgorzata Latocha; Krystian Pluta
Journal:  Med Chem Res       Date:  2015-03-25       Impact factor: 1.965

3.  Synthesis and anticancer activity of multisubstituted purines and xanthines with one or two propynylthio and aminobutynylthio groups.

Authors:  Alicja Kowalska; Krystian Pluta; Małgorzata Latocha
Journal:  Med Chem Res       Date:  2018-03-06       Impact factor: 1.965

4.  2-Arylamino-6-ethynylpurines are cysteine-targeting irreversible inhibitors of Nek2 kinase.

Authors:  Christopher J Matheson; Christopher R Coxon; Richard Bayliss; Kathy Boxall; Benoit Carbain; Andrew M Fry; Ian R Hardcastle; Suzannah J Harnor; Corine Mas-Droux; David R Newell; Mark W Richards; Mangaleswaran Sivaprakasam; David Turner; Roger J Griffin; Bernard T Golding; Céline Cano
Journal:  RSC Med Chem       Date:  2020-05-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.